Nivolumab and ipilimumab immunotherapy for hemodialysis patients with advanced renal cell carcinoma

  • Y. Kobayashi Kinki Central Hospital of Mutual Aid Association of Public School Teachers
  • H. Arai Kinki Central Hospital of Mutual Aid Association of Public School Teachers
  • M. Honda Kinki Central Hospital of Mutual Aid Association of Public School Teachers
Keywords: Hemodialysis, ipilimumab, renal cell carcinoma, nivolumab

Abstract

Combined immune checkpoint blockade with nivolumab and ipilimumab is standard therapy for the treatment of patients with previously untreated advanced renal cell carcinoma who are at intermediate or poor risk. However, data about the safety and efficacy of combined immune checkpoint blockade with nivolumab and ipilimumab in patients on hemodialysis are limited. Renal function has no known clinically important effects on the pharmacokinetics and clearance of nivolumab and ipilimumab. Further, most immune-related adverse events in patients on hemodialysis are thought to be manageable with the same treatments applied in patients with normal renal function.

   We present a case of advanced clear-cell renal cell carcinoma in a patient on hemodialysis who received combined immune checkpoint blockade with nivolumab and ipilimumab and who showed no evident signs of immune-related adverse events. Here, we confirm the safety and efficacy of combined immune checkpoint blockade with nivolumab and ipilimumab in a patient on hemodialysis.


Author Biographies

Y. Kobayashi, Kinki Central Hospital of Mutual Aid Association of Public School Teachers

Department of Urology

H. Arai, Kinki Central Hospital of Mutual Aid Association of Public School Teachers

Department of Urology

M. Honda, Kinki Central Hospital of Mutual Aid Association of Public School Teachers

Department of Urology

Published
2020-03-12
How to Cite
Kobayashi, Y., Arai, H., & Honda, M. (2020). Nivolumab and ipilimumab immunotherapy for hemodialysis patients with advanced renal cell carcinoma. Current Oncology, 27(4). https://doi.org/10.3747/co.27.6439
Section
Case Report